The Tate galleries and the National Portrait Gallery in London say they will no longer accept money from the Sacklers, the family who made, marketed and profited OxyContin through its company, Purdue Pharma. Marco Werman speaks to Benjamin Soskis, an expert on philanthropy at the Urban Institute. Is this a watershed moment in the controversy over cultural institutions funded by the Sacklers?